- Home
- CPOP vs CVKD Comparison
CPOP vs CVKD Comparison
Compare CPOP & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPOP
- CVKD
- Stock Information
- Founded
- CPOP 2007
- CVKD 2022
- Country
- CPOP China
- CVKD United States
- Employees
- CPOP N/A
- CVKD N/A
- Industry
- CPOP Services-Misc. Amusement & Recreation
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- CPOP Consumer Discretionary
- CVKD Health Care
- Exchange
- CPOP Nasdaq
- CVKD Nasdaq
- Market Cap
- CPOP 22.7M
- CVKD 20.8M
- IPO Year
- CPOP 2021
- CVKD 2023
- Fundamental
- Price
- CPOP $0.72
- CVKD $19.65
- Analyst Decision
- CPOP
- CVKD Strong Buy
- Analyst Count
- CPOP 0
- CVKD 1
- Target Price
- CPOP N/A
- CVKD $32.00
- AVG Volume (30 Days)
- CPOP 250.3K
- CVKD 51.3K
- Earning Date
- CPOP 11-15-2024
- CVKD 03-10-2025
- Dividend Yield
- CPOP N/A
- CVKD N/A
- EPS Growth
- CPOP N/A
- CVKD N/A
- EPS
- CPOP N/A
- CVKD N/A
- Revenue
- CPOP $47,381,918.00
- CVKD N/A
- Revenue This Year
- CPOP N/A
- CVKD N/A
- Revenue Next Year
- CPOP N/A
- CVKD N/A
- P/E Ratio
- CPOP N/A
- CVKD N/A
- Revenue Growth
- CPOP 155.52
- CVKD N/A
- 52 Week Low
- CPOP $0.61
- CVKD $5.40
- 52 Week High
- CPOP $9.67
- CVKD $21.30
- Technical
- Relative Strength Index (RSI)
- CPOP 30.01
- CVKD 60.33
- Support Level
- CPOP $0.61
- CVKD $19.07
- Resistance Level
- CPOP $1.29
- CVKD $20.46
- Average True Range (ATR)
- CPOP 0.11
- CVKD 1.41
- MACD
- CPOP -0.05
- CVKD -0.03
- Stochastic Oscillator
- CPOP 16.18
- CVKD 63.30
About CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.